Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;81(4):750-6.
doi: 10.1002/jmv.21457.

Epidemiological and clinical study of viral respiratory tract infections in children from Italy

Affiliations

Epidemiological and clinical study of viral respiratory tract infections in children from Italy

Massimiliano Fabbiani et al. J Med Virol. 2009 Apr.

Abstract

Impact of recently discovered viruses on epidemiology of acute respiratory tract infections (ARTI) is still unclear. We studied the impact of recently discovered human metapneumovirus (hMPV), human bocavirus (HBoV), and new coronaviruses (HCoV-NL63 and HKU1) on the global epidemiology of ARTI. From October 2006 to April 2007, 237 pediatric patients affected by ARTI were enrolled in our study. Specimens were tested for respiratory viruses by polymerase chain reaction. One hundred twenty-four out of 237 samples (52.3%) were positive for one or more viruses. Picornaviruses were the most prevalent viruses (n = 61, 43.6%), followed by respiratory syncytial virus (n = 34, 24.3%) and Adenovirus (n = 25, 17.9%); hMPV (n = 9, 6.4%) was the fourth most common virus detected. HBoV and HCoV showed a low prevalence (respectively 2.9% and 2.1%). RSV was the prevalent agent of LRTI (38%). Viruses were identified in more than 50% of the studied ARTI, providing useful information on clinical features and epidemiology of specific agents affecting children in cold months. Although routine surveillance of respiratory viruses does not seem cost-effective, continuous monitoring of ARTI etiology could be a useful tool for planning resources for the development of new vaccines and antiviral agents.

PubMed Disclaimer

References

    1. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung‐Lindell A, Andersson B. 2005. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102: 12891–12896. - PMC - PubMed
    1. Armstrong GL, Conn LA, Pinner RW. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281: 61–66. - PubMed
    1. Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Côte S, Peret TC, Erdmann DD, Anderson LJ. 2002. Virological features and clinical manifestations associated with human metapneumovirus: A new paramyxovirus responsible for acute respiratory‐tract infections in all age groups. J Infect Dis 186: 1330–1334. - PubMed
    1. Boivin G, De Serres G, Hamelin ME, Côte S, Argouin M, Tremblay G, Maranda‐Aubut R, Sauvageau C, Ouakki M, Boulianne N, Couture C. 2007. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long‐term care facility. Clin Infect Dis 44: 1152–1158. - PubMed
    1. Bosis S, Esposito S, Niesters HG, Crovari P, Osterhaus AD, Principi N. 2005. Impact of human metapneumovirus in childhood: Comparison with respiratory syncytial virus and influenza viruses. J Med Virol 75: 101–104. - PubMed

Publication types

MeSH terms